Consequently, we run the appropriate TOST test for each data set based on the rejection or acceptance of variance and distribution from the p values in Table \ref{stats-results}.  We derive several conclusions from each respective TOST test on each data set.
Therefore, we find that AKAP11 has a strong correlation with the diagnosis of BPD and a slight correlation to SCZ.  This is because we find a correlation for both SCZ and BPD when the variants are analyzed genetically using amino acids, but a statistically insignificant effect on SCZ when tested against the Canadian population. In both cases, we reject the null hypothesis that AKAP11 has no effect on the diagnosis of SCZ and BPD.